Stage-standardized and stage-specific survival among men with prostate cancer in the Nordic countries 2004–16: the NORDCAN survival studies
The distinct differences in stage distributions between the Nordic countries substantially contributed to the variation in prostate cancer survival.
Authors
- Frida E. Lundberg (ORCID: https://orcid.org/0000-0001-7061-7178)
- Helgi Birgisson (ORCID: https://orcid.org/0000-0002-8246-6159)
- Paul C. Lambert (ORCID: https://orcid.org/0000-0002-5337-663X)
- Lina Steinrud Mørch (ORCID: https://orcid.org/0000-0001-6506-2569)
- David Pettersson (ORCID: https://orcid.org/0000-0002-3123-1747)
- Signe Benzon Larsen (ORCID: https://orcid.org/0000-0001-9522-7678)
- Gerda Engholm (ORCID: https://orcid.org/0000-0002-5337-6234)
- Klaus Brasso (ORCID: https://orcid.org/0000-0001-6562-6416)
- Simon Konig (ORCID: https://orcid.org/0000-0002-1052-0304)
- Elínborg J. Ólafsdóttir
- Tom Børge Johannesen (ORCID: https://orcid.org/0000-0001-8633-1633)
- Therése Andersson (ORCID: https://orcid.org/0000-0001-8644-9041)
- Anna L.V. Johansson (ORCID: https://orcid.org/0000-0002-1191-7231)
- Søren Friis
Institutions
- University of Copenhagen (DK)
- National Board of Health and Welfare (SE)
- University of Leicester (GB)
- Cancer Institute (WIA) (IN)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Karolinska Institutet (SE)
- Cancer Registry of Norway (NO)
- Danish Cancer Society (DK)
- Icelandic Cancer Society (IS)
Publication Details
- Journal
- International Journal of Epidemiology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1093/ije/dyaf082
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kirsten og Freddy Johansens Fond